Supplementary Table 1 from A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice by Jo Waaler (1970758)

Figure 4 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

Supplementary figure 1 from A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma by Douglas W. Sborov (10760514)

Subjects:

S4. IGF-1R inhibition did not decrease FoxO1 protein levels in MCF-7 cells. from IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells by Ali Vaziri-Gohar (13862857)

Subjects:

Figure S4 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies by Rodrigo A. Toledo (14996709)

Subjects:

Figure S1 from The <i>MCT4</i> Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer by Stephen Yiu Chuen Choi (14996076)

Figure S6 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies by Rodrigo A. Toledo (14996709)

Subjects:

Supplementary Table 1-2, Figures S1-4 from siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutam... by Yoshiaki Yamamoto (2920581)

Subjects:

Table_1_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)

Table_2_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)

Table_3_Targeting metabolic pathways: a novel therapeutic direction for type 2 diabetes.docx by Zhihui Song (8270244)

Image_1_Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.tif by Emily C. Matchett (17037846)

“…</p>Results and conclusions<p>We demonstrated that NK3.3-LTV EVs target both sensitive and drug-resistant MM cell lines as well as primary patient MM cells in vitro, decreasing proliferation and inducing apoptotic cell death as well as or better than EVs from non-immortalized cells with no toxicity towards normal cells. …”

Image_2_Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.tif by Emily C. Matchett (17037846)

“…</p>Results and conclusions<p>We demonstrated that NK3.3-LTV EVs target both sensitive and drug-resistant MM cell lines as well as primary patient MM cells in vitro, decreasing proliferation and inducing apoptotic cell death as well as or better than EVs from non-immortalized cells with no toxicity towards normal cells. …”

Figure S4 from Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer by Elia Farah (14933502)

Subjects:

Supplementary Data from HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy by Michael F. Emmons (14935638)

Subjects:

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research by Shinji Maeda (445222)

Supplemental Figures from Rictor/mTORC2 Drives Progression and Therapeutic Resistance of <i>HER2</i>-Amplified Breast Cancers by Meghan Morrison Joly (4218496)

Subjects:

Data Supplement from Selective Release of a Cyclopamine Glucuronide Prodrug toward Stem-like Cancer Cell Inhibition in Glioblastoma by Anaïs Balbous (3425822)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…</p>Methods<p>Publications from 1 January 2013 to 31 December 2023 that described clinical research of AGs were identified by searching the Web of Science Core Collection Database. …”